[Pharmaco-epidemiological study on the prophylactic treatment of migraine. National inquiry on attitude to prescription practices by primary care physicians and neurologists in Franceø].
A pharmacoepidemiological survey was conducted in order to understand the pattern of migraine prophylactic drug utilization by French physicians. Neurologists and primary care physicians completed a phone-mail-phone questionnaire which inquired about migraine prophylactic treatment. French neurologists and PCP made the same use of migraine prophylaxis in terms of indication, time interval between treatment onset and evaluation, and duration. The two most commonly chosen migraine prophylactic agents were dihydroergotamine and beta-blockers. This study also showed the importance of considering quality of life to evaluate efficacy of migraine prophylaxis.
Lantéri-Minet
M
M
Département Douleur/Service de Neurologie, CHU de Nice.
Alchaar
H
H
Besson
G
G
Billé-Turc
F
F
Bouillat
J
J
Brudon
F
F
Donnet
A
A
Galletti
P
P
Maitre
M
M
Moene
Y
Y
Rambaud
G
G
Rostini
C
C
Valance
J
J
Gastaut
J L
JL
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D004087:Dihydroergotamine / Q000627:therapeutic use*; D005194:Family Practice; D005602:France; D006801:Humans; D008881:Migraine Disorders / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control*; D009462:Neurology; D010821:Physicians, Family; D011795:Surveys and Questionnaires; D013689:Telephone
D000319:Adrenergic beta-Antagonists; D004087:Dihydroergotamine